C135PS: Enlicitide Synthetic Peptide
Source: The enlicitide peptide was synthesized.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by enlicitide.
Purity: >98% by HPLC.C131P: Ulocuplumab Biosimilar, CXCR4/CD184 Monoclonal Antibody
Recombinant Human IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade ulocuplumab biosimilar specifically binds to the CXCR4/CD184 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ulocuplumab.C134PS: Octreotide Synthetic Peptide
Source: The octreotide peptide was synthesized.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Octreotide.
Purity: >99% by HPLC.C074PS: Semaglutide Synthetic Peptide
Source: The semaglutide peptide was synthesized.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by semaglutide.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.C074P: Semaglutide Biosimilar
Source: The recombinant peptide semaglutide biosimilar was produced in the semaglutide stable cell line.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by semaglutide.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.C073PS: Liraglutide Synthetic Peptide
Source: The recombinant peptide liraglutide synthetic peptide was produced in the liraglutide stable cell line.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by liraglutide.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.C128PS: Tirzepatide Synthetic Peptide
Source: The tirzepatide peptide was synthesized.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tirzepatide.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.C129PS: Retatrutide Synthetic Peptide
Source: The retatrutide peptide was synthesized.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by retatrutide.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.C104P: Dupilumab Biosimilar, IL4R alpha Monoclonal Antibody
Recombinant fully human IgG4 monoclonal antibody.
Specificity/Sensitivity: The monoclonal antibody dupilumab biosimilar specifically binds to the human IL4R alpha.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by dupilumab.C133P: Apamistamab Biosimilar, PTPRC/CD45 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade apamistamab biosimilar specifically binds to the PTPRC/CD45 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by apamistamab.C132P: Milatuzumab Biosimilar, CD74 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade milatuzumab biosimilar specifically binds to the CD74 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by milatuzumab.